Publications

5891 Results

Challenges of collecting health data and maintaining contact with an aging study population

Authors
J Hartline;K Anderson;D Marrah;E Klein
Journal / Conference
Society for Clinical Trials 33rd Annual Meeting (May 20-23, 2012, Miami, FL), oral presentation;
Year
2012
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Treatment of Helicobacter pylori in Latin America [correspondence; authors' reply]

Authors
ER Greenberg;GL Anderson;DR Morgan;J Torres;W Chey
Journal / Conference
Lancet 379:408-409
Year
2012
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID21777974
PMC
PMC3313469
Study Number(s)
S0701

Combination anastrozole and fulvestrant in metastatic breast cancer: SWOG S0226

Authors
R Mehta;W Barlow;K Albain;T Vandenberg;S Dakhil;N Tirumali;DL Lew;DF Hayes;JR Gralow;R Livingston;GN Hortobagyi
Journal / Conference
New England Journal of Medicine 367(5):435-444;
Year
2012
Research Committee(s)
Breast
PMID
PMID22853014
PMC
PMC3951300
Study Number(s)
S0226

Impact of body-mass index in the outcome of adult patients with acute myeloid leukemia

Authors
B Medeiros;M Othus;EH Estey;M Fang;F Appelbaum
Journal / Conference
Haematologica 97(9):1401-1404
Year
2012
Research Committee(s)
Leukemia
PMID
PMID22315487
PMC
PMCID3436242
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine (PCG) and gemcitabine/cisplatin (GC) in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987

Authors
J Bellmunt;H von der Maase;GM Mead;N Skonecza;M DeSantis;G Daugaard;J Heyer;N Houede;L Paz-Ares;L Laufman;E Winquist;D Raghavan;S Marreaud;S Collette;R Sylvester;R de Wit
Journal / Conference
Journal of Clinical Oncology 30(10):1107-1113;
Year
2012
Research Committee(s)
Genitourinary
PMID
PMID22370319
PMC
PMC3341152
Study Number(s)
30987

Design of a phase III clinical trial with prospective biomarker validation: SWOG S0819

Authors
M Redman;J Crowley;R Herbst;F Hirsch;D Gandara
Journal / Conference
Clinical Cancer Research 18(15):4004-4012
Year
2012
Research Committee(s)
Lung
PMID
PMID:22592956
PMC
PMC3409929
Study Number(s)
S0819

Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria [PMID22138096; PMC3260130]

Authors
EA Perez;AC Dueck;A McMullough;M Reinholz;K Tenner;N Davidson;J Gralow;LA Kutteh;DH Hillman;RB Jenkins;B Chen
Journal / Conference
Journal of the National Cancer Institute 104(2):159-162
Year
2012
Research Committee(s)
Breast
Study Number(s)
N9831

IMWG consensus on maintenance therapy in multiple myeloma

Authors
H Ludwig;B Durie;P McCarthy;A Palumbo;J San Miguel;B Barlogie;G Morgan;P Sonneveld;A Spencer;KC Andersen;T Facon;KA Stewart;H Einsele;MV Mateos;P Wijermans;A Waage;M Beksac;PG Richardson;C Hulin;R Niesvizky;H Lokhorst;O Landgren;PL Bergsagel;RZ Orlowski;A Hinke;M Cavo;M Attal
Journal / Conference
Blood 119(13):3003-3015
Year
2012
Research Committee(s)
Myeloma
PMID
PMID22271445
PMC
PMC3321864

Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. cooperative group trials

Authors
A Schroen;GR Petroni;H Wang;MJ Thielen;R Gray;J Benedetti;XF Wang;DJ Sargent;DL Wickerham;W Cronin;B Djulbegovic;CL Slingluff
Journal / Conference
Clinical Cancer Research 18(1):256-2662
Year
2012
Research Committee(s)
Multiple sites and Outcomes and Comparative Effectiveness

A randomized trial of dasatinib 100 mg vs imatinib 400 mg in newly diagnosed chronic phase chronic myeloid leukemia

Authors
J Radich;K Kopecky;F Appelbaum;S Kamel-Reid;W Stock;G Mainassy;E Paietta;M Wadleigh;R Larson;P Emmanuel;M Tallman;J Lipton;R Turner;B Druker
Journal / Conference
Blood 120(19):3898-3905;
Year
2012
Research Committee(s)
Leukemia
PMID
PMID22915637
PMC
PMC3496952
Study Number(s)
S0325